Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Raw Materials (2016 - 2018)

Historic Raw Materials for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 9 years, with Q4 2018 value amounting to $14.6 million.

  • Lifecore Biomedical, Inc. \De\'s Raw Materials rose 1041.65% to $14.6 million in Q4 2018 from the same period last year, while for Nov 2018 it was $14.6 million, marking a year-over-year increase of 1041.65%. This contributed to the annual value of $15.3 million for FY2018, which is 5048.24% up from last year.
  • Lifecore Biomedical, Inc. \De\'s Raw Materials amounted to $14.6 million in Q4 2018, which was up 1041.65% from $13.9 million recorded in Q3 2018.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Raw Materials ranged from a high of $15.3 million in Q2 2018 and a low of $4.2 million during Q4 2016
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Raw Materials value was $10.9 million (recorded in 2014), while the average stood at $11.2 million.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Raw Materials crashed by 6226.59% in 2016, and later surged by 21572.79% in 2017.
  • Lifecore Biomedical, Inc. \De\'s Raw Materials (Quarter) stood at $12.1 million in 2014, then fell by 8.15% to $11.1 million in 2015, then crashed by 62.27% to $4.2 million in 2016, then soared by 215.73% to $13.2 million in 2017, then rose by 10.42% to $14.6 million in 2018.
  • Its Raw Materials stands at $14.6 million for Q4 2018, versus $13.9 million for Q3 2018 and $15.3 million for Q2 2018.